Merck Global Health Innovation Fund

Portfolio Co Investors 2026 for Merck Global Health Innovation Fund: investors, rounds, and co-investor patterns from StartupFundraising.com research.

Merck Global Health Innovation Fund accounts for 10 tracked companies with verified cap-table data, 10 of which disclose round sizes totalling $1B. The median disclosed raise is $50M, and the largest is BridgeHealth at $450M, ahead of Preventice Solutions ($137M) and Tasso ($120M).

The names that recur most often on these co-invested cap tables are Merck Global Health Innovation Fund (10 companies), General Catalyst (1 company), 7wireVentures (1 company), Kleiner Perkins (1 company), Leaps by Bayer (1 company), GreatPoint Ventures (1 company). By latest disclosed round, the market skews Series B (3), Series A (2), Series D (1), Seed (1).

Best funded Merck Global Health Innovation Fund companies

  1. BridgeHealth — $450M (latest: Series D)
  2. Preventice Solutions — $137M (latest: Series B)
  3. Tasso — $120M (latest: Series B)
  4. Antidote.me — $60M (latest: Seed)
  5. Caresync.co — $50M (latest: Series A)
  6. Redica Systems — $49M (latest: Growth)
  7. AeroSafe Global — $43M (latest: Series F)
  8. Prognos Health — $42M (latest: Series C)
  9. Unnatural Products — $35M (latest: Series A)
  10. PreciseDx — $32M (latest: Series B)

Merck Global Health Innovation Fund — related firms and companies (53)

Merck Global Health Innovation Fund alternatives · All research reports